Clinical trial
A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of…
NCT00174512 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174512 |
|---|---|
| Title | A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade |
| Official title | A Methodological Open-Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarisation and QT Interval At Fixed Heart Rate Under Autonomic Blockade |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Patients With Pace Makers But no Evidence of Ischemic Heart Disease |
| Intervention type | Drug |
| Interventions | GTN, Moxifloxacin |
| Enrollment | 36 |
| Start date | Mar 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 8, 2006 |
| Countries | Belgium, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: